← Back to Search

Pharmacy Use Survey for Health Accessibility

N/A

Waitlist Available

Led By Whisler, PharmD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English-speakers

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within one year of study initiation

Awards & highlights

Study Summary

This trial will survey patients on specialty meds to find out how often they must use multiple pharmacies & why.

Who is the study for?

This survey is for adults over 18 who speak English and are patients at the conducting institution. They must have been prescribed a specialty medication recently, within the last three months, and be able to give informed consent.Check my eligibility

What is being tested?

The study involves a survey designed to measure how often people need to use multiple pharmacies for their specialty medications, what they think about this practice, and what might make it more likely to happen.See study design

What are the potential side effects?

Since this trial involves taking a survey rather than testing a medical intervention or drug, there are no direct physical side effects associated with participating in this research.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within one year of study initiation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within one year of study initiation

This trial's timeline: 3 weeks for screening, Varies for treatment, and within one year of study initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Patients using Multiple Pharmacies

Secondary outcome measures

Experience with obtaining and administering medications

Method of obtaining medications

Self-reported adherence and barriers

Trial Design

1Treatment groups

Experimental Treatment

Group I: Specialty Pharmacy PatientExperimental Treatment1 Intervention

Patients who have been prescribed at least one selected specialty medication

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, Los AngelesOTHER

1,528 Previous Clinical Trials

10,276,051 Total Patients Enrolled

The Cleveland ClinicOTHER

1,026 Previous Clinical Trials

1,365,276 Total Patients Enrolled

University of Illinois at ChicagoOTHER

607 Previous Clinical Trials

1,558,555 Total Patients Enrolled

Media Library

Specialty Pharmacy Patient Clinical Trial Eligibility Overview. Trial Name: NCT05035225 — N/A

Health Accessibility Research Study Groups: Specialty Pharmacy Patient

Health Accessibility Clinical Trial 2023: Specialty Pharmacy Patient Highlights & Side Effects. Trial Name: NCT05035225 — N/A

Specialty Pharmacy Patient 2023 Treatment Timeline for Medical Study. Trial Name: NCT05035225 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being accepted into this clinical research program?

"Data hosted on clinicaltrials.gov affirms that the recruitment period for this trial has come to a close; it was initially posted on July 31, 2023 and the last update came through August 7th, 2023. Yet there are still two other trials open for enrollment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A National Survey on the Prevalence and Impact of Multiple Pharmacy Use in Specialty Pharmacy

Ryan Whisler 2023. "A National Survey on the Prevalence and Impact of Multiple Pharmacy Use in Specialty Pharmacy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05035225.